-
1
-
-
84876854791
-
Iron and cancer: More ore to be mined
-
Torti, S.V.; Torti, F.M. Iron and cancer: More ore to be mined. Nat. Rev. Cancer 2013, 13, 342-355.
-
(2013)
Nat. Rev. Cancer
, vol.13
, pp. 342-355
-
-
Torti, S.V.1
Torti, F.M.2
-
2
-
-
0025302688
-
Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects
-
Cazzola, M.; Bergamaschi, G.; Dezza, L.; Arosio, P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: Achievements and prospects. Blood 1990, 75, 1903-1919.
-
(1990)
Blood
, vol.75
, pp. 1903-1919
-
-
Cazzola, M.1
Bergamaschi, G.2
Dezza, L.3
Arosio, P.4
-
3
-
-
85016957239
-
Iron overload induces apoptosis of murine preosteoblast cells via ros and inhibition of AKT pathway
-
Ke, J.Y.; Cen, W.J.; Zhou, X.Z.; Li, Y.R.; Kong, W.D.; Jiang, J.W. Iron overload induces apoptosis of murine preosteoblast cells via ros and inhibition of AKT pathway. Oral Dis. 2017.
-
(2017)
Oral Dis
-
-
Ke, J.Y.1
Cen, W.J.2
Zhou, X.Z.3
Li, Y.R.4
Kong, W.D.5
Jiang, J.W.6
-
4
-
-
84995451725
-
Iron overload induced death of osteoblasts in vitro: Involvement of the mitochondrial apoptotic pathway
-
Tian, Q.; Wu, S.; Dai, Z.; Yang, J.; Zheng, J.; Zheng, Q.; Liu, Y. Iron overload induced death of osteoblasts in vitro: Involvement of the mitochondrial apoptotic pathway. Peer J. 2016, 4, e2611.
-
(2016)
Peer J
, vol.2
, pp. 2611
-
-
Tian, Q.1
Wu, S.2
Dai, Z.3
Yang, J.4
Zheng, J.5
Zheng, Q.6
Liu, Y.7
-
5
-
-
84971265142
-
Iron overload induced by ferric ammonium citrate triggers reactive oxygen species-mediated apoptosis via both extrinsic and intrinsic pathways in human hepatic cells
-
Li, S.W.; Liu, C.M.; Guo, J.; Marcondes, A.M.; Deeg, J.; Li, X.; Guan, F. Iron overload induced by ferric ammonium citrate triggers reactive oxygen species-mediated apoptosis via both extrinsic and intrinsic pathways in human hepatic cells. Hum. Exp. Toxicol. 2016, 35, 598-607.
-
(2016)
Hum. Exp. Toxicol
, vol.35
, pp. 598-607
-
-
Li, S.W.1
Liu, C.M.2
Guo, J.3
Marcondes, A.M.4
Deeg, J.5
Li, X.6
Guan, F.7
-
6
-
-
84861541814
-
Ferroptosis: An iron-dependent form of nonapoptotic cell death
-
Dixon, S.J.; Lemberg, K.M.; Lamprecht, M.R.; Skouta, R.; Zaitsev, E.M.; Gleason, C.E.; Patel, D.N.; Bauer, A.J.; Cantley, A.M.; Yang, W.S. et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 2012, 149, 1060-1072.
-
(2012)
Cell
, vol.149
, pp. 1060-1072
-
-
Dixon, S.J.1
Lemberg, K.M.2
Lamprecht, M.R.3
Skouta, R.4
Zaitsev, E.M.5
Gleason, C.E.6
Patel, D.N.7
Bauer, A.J.8
Cantley, A.M.9
Yang, W.S.10
-
7
-
-
84958103915
-
Ferroptosis: Death by lipid peroxidation
-
Yang, W.S.; Stockwell, B.R. Ferroptosis: Death by lipid peroxidation. Trends Cell Biol. 2016, 26, 165-176.
-
(2016)
Trends Cell Biol
, vol.26
, pp. 165-176
-
-
Yang, W.S.1
Stockwell, B.R.2
-
8
-
-
85012272811
-
Lipid peroxidation in cell death. Biochem. Biophys. Res
-
Gaschler, M.M.; Stockwell, B.R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 2017, 482, 419-425.
-
(2017)
Commun
, vol.482
, pp. 419-425
-
-
Gaschler, M.M.1
Stockwell, B.R.2
-
9
-
-
84962637563
-
Mechanisms of ferroptosis
-
Cao, J.Y.; Dixon, S.J. Mechanisms of ferroptosis. Cell Mol. Life Sci. 2016, 73, 2195-2209.
-
(2016)
Cell Mol. Life Sci
, vol.73
, pp. 2195-2209
-
-
Cao, J.Y.1
Dixon, S.J.2
-
10
-
-
85000658863
-
Ferroptosis, a new form of cell death, and its relationships with tumourous diseases
-
Yu, H.; Guo, P.; Xie, X.; Wang, Y.; Chen, G. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J. Cell Mol. Med. 2017, 21, 648-657.
-
(2017)
J. Cell Mol. Med
, vol.21
, pp. 648-657
-
-
Yu, H.1
Guo, P.2
Xie, X.3
Wang, Y.4
Chen, G.5
-
11
-
-
58149305448
-
Role of iron in carcinogenesis: Cancer as a ferrotoxic disease
-
Toyokuni, S. Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci. 2009, 100, 9-16.
-
(2009)
Cancer Sci
, vol.100
, pp. 9-16
-
-
Toyokuni, S.1
-
12
-
-
85018770280
-
Iron and thiol redox signaling in cancer: An exquisite balance to escape ferroptosis
-
Toyokuni, S.; Ito, F.; Yamashita, K.; Okazaki, Y.; Akatsuka, S. Iron and thiol redox signaling in cancer: An exquisite balance to escape ferroptosis. Free Radic. Biol. Med. 2017, 108, 610-626.
-
(2017)
Free Radic. Biol. Med
, vol.108
, pp. 610-626
-
-
Toyokuni, S.1
Ito, F.2
Yamashita, K.3
Okazaki, Y.4
Akatsuka, S.5
-
13
-
-
0022634070
-
Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats
-
Ebina, Y.; Okada, S.; Hamazaki, S.; Ogino, F.; Li, J.L.; Midorikawa, O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J. Natl. Cancer Inst. 1986, 76, 107-113.
-
(1986)
J. Natl. Cancer Inst
, vol.76
, pp. 107-113
-
-
Ebina, Y.1
Okada, S.2
Hamazaki, S.3
Ogino, F.4
Li, J.L.5
Midorikawa, O.6
-
14
-
-
0029896229
-
Cloning and expression in escherichia coli of the OGG1 gene of saccharomyces cerevisiae, which codes for a dna glycosylase that excises 7,8-dihydro-8-oxoguanine and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine
-
Van der Kemp, P.A.; Thomas, D.; Barbey, R.; de Oliveira, R.; Boiteux, S. Cloning and expression in escherichia coli of the OGG1 gene of saccharomyces cerevisiae, which codes for a dna glycosylase that excises 7,8-dihydro-8-oxoguanine and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine. Proc. Natl. Acad. Sci. USA 1996, 93, 5197-5202.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 5197-5202
-
-
Van Der Kemp, P.A.1
Thomas, D.2
Barbey, R.3
De Oliveira, R.4
Boiteux, S.5
-
15
-
-
0030220956
-
Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily
-
Nash, H.M.; Bruner, S.D.; Schärer, O.D.; Kawate, T.; Addona, T.A.; Spooner, E.; Lane, W.S.; Verdine, G.L. Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily. Curr. Biol. 1996, 6, 968-980.
-
(1996)
Curr. Biol
, vol.6
, pp. 968-980
-
-
Nash, H.M.1
Bruner, S.D.2
Schärer, O.D.3
Kawate, T.4
Addona, T.A.5
Spooner, E.6
Lane, W.S.7
Verdine, G.L.8
-
16
-
-
0030912695
-
Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutm homologue
-
Aburatani, H.; Hippo, Y.; Ishida, T.; Takashima, R.; Matsuba, C.; Kodama, T.; Takao, M.; Yasui, A.; Yamamoto, K.; Asano, M. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutm homologue. Cancer Res. 1997, 57, 2151-2156.
-
(1997)
Cancer Res
, vol.57
, pp. 2151-2156
-
-
Aburatani, H.1
Hippo, Y.2
Ishida, T.3
Takashima, R.4
Matsuba, C.5
Kodama, T.6
Takao, M.7
Yasui, A.8
Yamamoto, K.9
Asano, M.10
-
17
-
-
35448952080
-
Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C
-
Kato, J.; Miyanishi, K.; Kobune, M.; Nakamura, T.; Takada, K.; Takimoto, R.; Kawano, Y.; Takahashi, S.; Takahashi, M.; Sato, Y. et al. Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J. Gastroenterol. 2007, 42, 830-836.
-
(2007)
J. Gastroenterol
, vol.42
, pp. 830-836
-
-
Kato, J.1
Miyanishi, K.2
Kobune, M.3
Nakamura, T.4
Takada, K.5
Takimoto, R.6
Kawano, Y.7
Takahashi, S.8
Takahashi, M.9
Sato, Y.10
-
18
-
-
0035893552
-
Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet
-
Kato, J.; Kobune, M.; Nakamura, T.; Kuroiwa, G.; Takada, K.; Takimoto, R.; Sato, Y.; Fujikawa, K.; Takahashi, M.; Takayama, T. et al. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res. 2001, 61, 8697-8702.
-
(2001)
Cancer Res
, vol.61
, pp. 8697-8702
-
-
Kato, J.1
Kobune, M.2
Nakamura, T.3
Kuroiwa, G.4
Takada, K.5
Takimoto, R.6
Sato, Y.7
Fujikawa, K.8
Takahashi, M.9
Takayama, T.10
-
19
-
-
47649090354
-
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial
-
Zacharski, L.R.; Chow, B.K.; Howes, P.S.; Shamayeva, G.; Baron, J.A.; Dalman, R.L.; Malenka, D.J.; Ozaki, C.K.; Lavori, P.W. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial. J. Natl. Cancer Inst. 2008, 100, 996-1002.
-
(2008)
J. Natl. Cancer Inst
, vol.100
, pp. 996-1002
-
-
Zacharski, L.R.1
Chow, B.K.2
Howes, P.S.3
Shamayeva, G.4
Baron, J.A.5
Dalman, R.L.6
Malenka, D.J.7
Ozaki, C.K.8
Lavori, P.W.9
-
20
-
-
0031469841
-
Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis
-
Kasai, H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 1997, 387, 147-163.
-
(1997)
Mutat. Res
, vol.387
, pp. 147-163
-
-
Kasai, H.1
-
21
-
-
0034005479
-
Overexpression of the HOGG1 gene and high 8-hydroxy-2′-deoxyguanosine (8-OHDG) lyase activity in human colorectal carcinoma: Regulation mechanism of the 8-OHDG level in DNA
-
Kondo, S.; Toyokuni, S.; Tanaka, T.; Hiai, H.; Onodera, H.; Kasai, H.; Imamura, M. Overexpression of the HOGG1 gene and high 8-hydroxy-2′-deoxyguanosine (8-OHDG) lyase activity in human colorectal carcinoma: Regulation mechanism of the 8-OHDG level in DNA. Clin. Cancer Res. 2000, 6, 1394-1400.
-
(2000)
Clin. Cancer Res
, vol.6
, pp. 1394-1400
-
-
Kondo, S.1
Toyokuni, S.2
Tanaka, T.3
Hiai, H.4
Onodera, H.5
Kasai, H.6
Imamura, M.7
-
22
-
-
0029932905
-
Overexpression of human mutt homologue gene messenger RNA in renal-cell carcinoma: Evidence of persistent oxidative stress in cancer
-
Okamoto, K.; Toyokuni, S.; Kim, W.J.; Ogawa, O.; Kakehi, Y.; Arao, S.; Hiai, H.; Yoshida, O. Overexpression of human mutt homologue gene messenger RNA in renal-cell carcinoma: Evidence of persistent oxidative stress in cancer. Int. J. Cancer 1996, 65, 437-441.
-
(1996)
Int. J. Cancer
, vol.65
, pp. 437-441
-
-
Okamoto, K.1
Toyokuni, S.2
Kim, W.J.3
Ogawa, O.4
Kakehi, Y.5
Arao, S.6
Hiai, H.7
Yoshida, O.8
-
23
-
-
84861355868
-
Hepcidin and iron homeostasis
-
Ganz, T.; Nemeth, E. Hepcidin and iron homeostasis. Biochim. Biophys. Acta 2012, 1823, 1434-1443.
-
(2012)
Biochim. Biophys. Acta
, vol.1823
, pp. 1434-1443
-
-
Ganz, T.1
Nemeth, E.2
-
24
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
Nemeth, E.; Tuttle, M.S.; Powelson, J.; Vaughn, M.B.; Donovan, A.; Ward, D.M.; Ganz, T.; Kaplan, J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306, 2090-2093.
-
(2004)
Science
, vol.306
, pp. 2090-2093
-
-
Nemeth, E.1
Tuttle, M.S.2
Powelson, J.3
Vaughn, M.B.4
Donovan, A.5
Ward, D.M.6
Ganz, T.7
Kaplan, J.8
-
25
-
-
18244389488
-
Iron-dependent regulation of the divalent metal ion transporter
-
Gunshin, H.; Allerson, C.R.; Polycarpou-Schwarz, M.; Rofts, A.; Rogers, J.T.; Kishi, F.; Hentze, M.W.; Rouault, T.A.; Andrews, N.C.; Hediger, M.A. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett. 2001, 509, 309-316.
-
(2001)
FEBS Lett
, vol.509
, pp. 309-316
-
-
Gunshin, H.1
Allerson, C.R.2
Polycarpou-Schwarz, M.3
Rofts, A.4
Rogers, J.T.5
Kishi, F.6
Hentze, M.W.7
Rouault, T.A.8
Andrews, N.C.9
Hediger, M.A.10
-
26
-
-
77953810574
-
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage
-
Arosio, P.; Levi, S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim. Biophys. Acta 2010, 1800, 783-792.
-
(2010)
Biochim. Biophys. Acta
, vol.1800
, pp. 783-792
-
-
Arosio, P.1
Levi, S.2
-
27
-
-
84899746695
-
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
-
Mancias, J.D.; Wang, X.; Gygi, S.P.; Harper, J.W.; Kimmelman, A.C. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 2014, 509, 105-109.
-
(2014)
Nature
, vol.509
, pp. 105-109
-
-
Mancias, J.D.1
Wang, X.2
Gygi, S.P.3
Harper, J.W.4
Kimmelman, A.C.5
-
28
-
-
77955615050
-
Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert
-
Maffettone, C.; Chen, G.; Drozdov, I.; Ouzounis, C.; Pantopoulos, K. Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert. PLoS ONE 2010, 5, e10163.
-
(2010)
Plos ONE
, vol.5
-
-
Maffettone, C.1
Chen, G.2
Drozdov, I.3
Ouzounis, C.4
Pantopoulos, K.5
-
29
-
-
33644770587
-
Activation of transferrin receptor 1 by c-MYC enhances cellular proliferation and tumorigenesis
-
O’Donnell, K.A.; Yu, D.; Zeller, K.I.; Kim, J.W.; Racke, F.; Thomas-Tikhonenko, A.; Dang, C.V. Activation of transferrin receptor 1 by c-MYC enhances cellular proliferation and tumorigenesis. Mol. Cell Biol. 2006, 26, 2373-2386.
-
(2006)
Mol. Cell Biol
, vol.26
, pp. 2373-2386
-
-
O’Donnell, K.A.1
Yu, D.2
Zeller, K.I.3
Kim, J.W.4
Racke, F.5
Thomas-Tikhonenko, A.6
Dang, C.V.7
-
30
-
-
0033588021
-
Transferrin receptor induction by hypoxia. Hif-1-mediated transcriptional activation and cell-specific post-transcriptional regulation
-
Tacchini, L.; Bianchi, L.; Bernelli-Zazzera, A.; Cairo, G. Transferrin receptor induction by hypoxia. Hif-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J. Biol. Chem. 1999, 274, 24142-24146.
-
(1999)
J. Biol. Chem
, vol.274
, pp. 24142-24146
-
-
Tacchini, L.1
Bianchi, L.2
Bernelli-Zazzera, A.3
Cairo, G.4
-
31
-
-
74849109475
-
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
-
Habashy, H.O.; Powe, D.G.; Staka, C.M.; Rakha, E.A.; Ball, G.; Green, A.R.; Aleskandarany, M.; Paish, E.C.; Douglas Macmillan, R.; Nicholson, R.I. et al. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res. Treat. 2010, 119, 283-293.
-
(2010)
Breast Cancer Res. Treat
, vol.119
, pp. 283-293
-
-
Habashy, H.O.1
Powe, D.G.2
Staka, C.M.3
Rakha, E.A.4
Ball, G.5
Green, A.R.6
Aleskandarany, M.7
Paish, E.C.8
Douglas Macmillan, R.9
Nicholson, R.I.10
-
32
-
-
84946064733
-
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis
-
Jeong, D.E.; Song, H.J.; Lim, S.; Lee, S.J.; Lim, J.E.; Nam, D.H.; Joo, K.M.; Jeong, B.C.; Jeon, S.S.; Choi, H.Y. et al. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget 2015, 6, 33046-33064.
-
(2015)
Oncotarget
, vol.6
, pp. 33046-33064
-
-
Jeong, D.E.1
Song, H.J.2
Lim, S.3
Lee, S.J.4
Lim, J.E.5
Nam, D.H.6
Joo, K.M.7
Jeong, B.C.8
Jeon, S.S.9
Choi, H.Y.10
-
33
-
-
85015710412
-
Iron addiction: A novel therapeutic target in ovarian cancer
-
Basuli, D.; Tesfay, L.; Deng, Z.; Paul, B.; Yamamoto, Y.; Ning, G.; Xian, W.; McKeon, F.; Lynch, M.; Crum, C.P. et al. Iron addiction: A novel therapeutic target in ovarian cancer. Oncogene 2017, 36, 4089-4099.
-
(2017)
Oncogene
, vol.36
, pp. 4089-4099
-
-
Basuli, D.1
Tesfay, L.2
Deng, Z.3
Paul, B.4
Yamamoto, Y.5
Ning, G.6
Xian, W.7
McKeon, F.8
Lynch, M.9
Crum, C.P.10
-
34
-
-
79952227712
-
Ironing out cancer
-
Torti, S.V.; Torti, F.M. Ironing out cancer. Cancer Res. 2011, 71, 1511-1514.
-
(2011)
Cancer Res
, vol.71
, pp. 1511-1514
-
-
Torti, S.V.1
Torti, F.M.2
-
35
-
-
0033613854
-
Coordinated regulation of iron-controlling genes, H-ferritin and Irp2, by c-MYC
-
Wu, K.J.; Polack, A.; Dalla-Favera, R. Coordinated regulation of iron-controlling genes, H-ferritin and Irp2, by c-MYC. Science 1999, 283, 676-679.
-
(1999)
Science
, vol.283
, pp. 676-679
-
-
Wu, K.J.1
Polack, A.2
Dalla-Favera, R.3
-
36
-
-
0036669914
-
Repression of ferritin expression modulates cell responsiveness to H-ras-induced growth
-
Kakhlon, O.; Gruenbaum, Y.; Cabantchik, Z.I. Repression of ferritin expression modulates cell responsiveness to H-ras-induced growth. Biochem. Soc. Trans. 2002, 30, 777-780.
-
(2002)
Biochem. Soc. Trans
, vol.30
, pp. 777-780
-
-
Kakhlon, O.1
Gruenbaum, Y.2
Cabantchik, Z.I.3
-
37
-
-
78149250305
-
Polarization dictates iron handling by inflammatory and alternatively activated macrophages
-
Corna, G.; Campana, L.; Pignatti, E.; Castiglioni, A.; Tagliafico, E.; Bosurgi, L.; Campanella, A.; Brunelli, S.; Manfredi, A.A.; Apostoli, P. et al. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 2010, 95, 1814-1822.
-
(2010)
Haematologica
, vol.95
, pp. 1814-1822
-
-
Corna, G.1
Campana, L.2
Pignatti, E.3
Castiglioni, A.4
Tagliafico, E.5
Bosurgi, L.6
Campanella, A.7
Brunelli, S.8
Manfredi, A.A.9
Apostoli, P.10
-
38
-
-
85019715011
-
Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy
-
Latunde-Dada, G.O. Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy. Biochim. Biophys. Acta 2017, 1861, 1893-1900.
-
(1861)
Biochim. Biophys. Acta
, vol.2017
, pp. 1893-1900
-
-
Latunde-Dada, G.O.1
-
39
-
-
85015005588
-
Iron and ferroptosis: A still ill-defined liaison
-
Doll, S.; Conrad, M. Iron and ferroptosis: A still ill-defined liaison. IUBMB Life 2017, 69, 423-434.
-
(2017)
IUBMB Life
, vol.69
, pp. 423-434
-
-
Doll, S.1
Conrad, M.2
-
40
-
-
84957429081
-
Ferroptosis: Process and function
-
Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D. Ferroptosis: Process and function. Cell Death Differ. 2016, 23, 369-379.
-
(2016)
Cell Death Differ
, vol.23
, pp. 369-379
-
-
Xie, Y.1
Hou, W.2
Song, X.3
Yu, Y.4
Huang, J.5
Sun, X.6
Kang, R.7
Tang, D.8
-
41
-
-
68949105901
-
Hydroxyl radical is produced via the fenton reaction in submitochondrial particles under oxidative stress: Implications for diseases associated with iron accumulation
-
Thomas, C.; Mackey, M.M.; Diaz, A.A.; Cox, D.P. Hydroxyl radical is produced via the fenton reaction in submitochondrial particles under oxidative stress: Implications for diseases associated with iron accumulation. Redox Rep. 2009, 14, 102-108.
-
(2009)
Redox Rep.
, vol.14
, pp. 102-108
-
-
Thomas, C.1
Mackey, M.M.2
Diaz, A.A.3
Cox, D.P.4
-
42
-
-
84897059782
-
Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models
-
Skouta, R.; Dixon, S.J.; Wang, J.; Dunn, D.E.; Orman, M.; Shimada, K.; Rosenberg, P.A.; Lo, D.C.; Weinberg, J.M.; Linkermann, A. et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 2014, 136, 4551-4556.
-
(2014)
J. Am. Chem. Soc
, vol.136
, pp. 4551-4556
-
-
Skouta, R.1
Dixon, S.J.2
Wang, J.3
Dunn, D.E.4
Orman, M.5
Shimada, K.6
Rosenberg, P.A.7
Lo, D.C.8
Weinberg, J.M.9
Linkermann, A.10
-
43
-
-
84892685001
-
Regulation of ferroptotic cancer cell death by GPX4
-
Yang, W.S.; SriRamaratnam, R.; Welsch, M.E.; Shimada, K.; Skouta, R.; Viswanathan, V.S.; Cheah, J.H.; Clemons, P.A.; Shamji, A.F.; Clish, C.B. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014, 156, 317-331.
-
(2014)
Cell
, vol.156
, pp. 317-331
-
-
Yang, W.S.1
Sriramaratnam, R.2
Welsch, M.E.3
Shimada, K.4
Skouta, R.5
Viswanathan, V.S.6
Cheah, J.H.7
Clemons, P.A.8
Shamji, A.F.9
Clish, C.B.10
-
44
-
-
50049133588
-
Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death
-
Seiler, A.; Schneider, M.; Förster, H.; Roth, S.; Wirth, E.K.; Culmsee, C.; Plesnila, N.; Kremmer, E.; Rådmark, O.; Wurst, W. et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008, 8, 237-248.
-
(2008)
Cell Metab
, vol.8
, pp. 237-248
-
-
Seiler, A.1
Schneider, M.2
Förster, H.3
Roth, S.4
Wirth, E.K.5
Culmsee, C.6
Plesnila, N.7
Kremmer, E.8
Rådmark, O.9
Wurst, W.10
-
45
-
-
11244270281
-
Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis
-
Ran, Q.; Liang, H.; Gu, M.; Qi, W.; Walter, C.A.; Roberts, L.J.; Herman, B.; Richardson, A.; van Remmen, H. Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J. Biol. Chem. 2004, 279, 55137-55146.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 55137-55146
-
-
Ran, Q.1
Liang, H.2
Gu, M.3
Qi, W.4
Walter, C.A.5
Roberts, L.J.6
Herman, B.7
Richardson, A.8
Van Remmen, H.9
-
46
-
-
0037932865
-
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
-
Dolma, S.; Lessnick, S.L.; Hahn, W.C.; Stockwell, B.R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 2003, 3, 285-296.
-
(2003)
Cancer Cell
, vol.3
, pp. 285-296
-
-
Dolma, S.1
Lessnick, S.L.2
Hahn, W.C.3
Stockwell, B.R.4
-
47
-
-
40849085503
-
Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells
-
Yang, W.S.; Stockwell, B.R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 2008, 15, 234-245.
-
(2008)
Chem. Biol
, vol.15
, pp. 234-245
-
-
Yang, W.S.1
Stockwell, B.R.2
-
48
-
-
34250372956
-
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels
-
Yagoda, N.; von Rechenberg, M.; Zaganjor, E.; Bauer, A.J.; Yang, W.S.; Fridman, D.J.; Wolpaw, A.J.; Smukste, I.; Peltier, J.M.; Boniface, J.J. et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 2007, 447, 864-868.
-
(2007)
Nature
, vol.447
, pp. 864-868
-
-
Yagoda, N.1
Von Rechenberg, M.2
Zaganjor, E.3
Bauer, A.J.4
Yang, W.S.5
Fridman, D.J.6
Wolpaw, A.J.7
Smukste, I.8
Peltier, J.M.9
Boniface, J.J.10
-
49
-
-
84916241447
-
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors
-
Lachaier, E.; Louandre, C.; Godin, C.; Saidak, Z.; Baert, M.; Diouf, M.; Chauffert, B.; Galmiche, A. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res. 2014, 34, 6417-6422.
-
(2014)
Anticancer Res
, vol.34
, pp. 6417-6422
-
-
Lachaier, E.1
Louandre, C.2
Godin, C.3
Saidak, Z.4
Baert, M.5
Diouf, M.6
Chauffert, B.7
Galmiche, A.8
-
50
-
-
84880296973
-
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
-
Louandre, C.; Ezzoukhry, Z.; Godin, C.; Barbare, J.C.; Mazière, J.C.; Chauffert, B.; Galmiche, A. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int. J. Cancer 2013, 133, 1732-1742.
-
(2013)
Int. J. Cancer
, vol.133
, pp. 1732-1742
-
-
Louandre, C.1
Ezzoukhry, Z.2
Godin, C.3
Barbare, J.C.4
Mazière, J.C.5
Chauffert, B.6
Galmiche, A.7
-
51
-
-
84901323900
-
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis
-
Dixon, S.J.; Patel, D.N.; Welsch, M.; Skouta, R.; Lee, E.D.; Hayano, M.; Thomas, A.G.; Gleason, C.E.; Tatonetti, N.P.; Slusher, B.S. et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife 2014, 3, e02523.
-
(2014)
Elife
, vol.3
-
-
Dixon, S.J.1
Patel, D.N.2
Welsch, M.3
Skouta, R.4
Lee, E.D.5
Hayano, M.6
Thomas, A.G.7
Gleason, C.E.8
Tatonetti, N.P.9
Slusher, B.S.10
-
52
-
-
84947035915
-
HSPB1 as a novel regulator of ferroptotic cancer cell death
-
Sun, X.; Ou, Z.; Xie, M.; Kang, R.; Fan, Y.; Niu, X.; Wang, H.; Cao, L.; Tang, D. HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene 2015, 34, 5617-5625.
-
(2015)
Oncogene
, vol.34
, pp. 5617-5625
-
-
Sun, X.1
Ou, Z.2
Xie, M.3
Kang, R.4
Fan, Y.5
Niu, X.6
Wang, H.7
Cao, L.8
Tang, D.9
-
53
-
-
84957431913
-
Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells
-
Eling, N.; Reuter, L.; Hazin, J.; Hamacher-Brady, A.; Brady, N.R. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2015, 2, 517-532.
-
(2015)
Oncoscience
, vol.2
, pp. 517-532
-
-
Eling, N.1
Reuter, L.2
Hazin, J.3
Hamacher-Brady, A.4
Brady, N.R.5
-
54
-
-
84959194657
-
Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate
-
Greenshields, A.L.; Shepherd, T.G.; Hoskin, D.W. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate. Mol. Carcinog. 2017, 56, 75-93.
-
(2017)
Mol. Carcinog
, vol.56
, pp. 75-93
-
-
Greenshields, A.L.1
Shepherd, T.G.2
Hoskin, D.W.3
-
55
-
-
84995468814
-
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
-
Doll, S.; Proneth, B.; Tyurina, Y.Y.; Panzilius, E.; Kobayashi, S.; Ingold, I.; Irmler, M.; Beckers, J.; Aichler, M.; Walch, A. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 2017, 13, 91-98.
-
(2017)
Nat. Chem. Biol
, vol.13
, pp. 91-98
-
-
Doll, S.1
Proneth, B.2
Tyurina, Y.Y.3
Panzilius, E.4
Kobayashi, S.5
Ingold, I.6
Irmler, M.7
Beckers, J.8
Aichler, M.9
Walch, A.10
-
56
-
-
84954379174
-
Loss of cysteinyl-tRNA synthetase (Cars) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation
-
Hayano, M.; Yang, W.S.; Corn, C.K.; Pagano, N.C.; Stockwell, B.R. Loss of cysteinyl-tRNA synthetase (cars) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. 2016, 23, 270-278.
-
(2016)
Cell Death Differ
, vol.23
, pp. 270-278
-
-
Hayano, M.1
Yang, W.S.2
Corn, C.K.3
Pagano, N.C.4
Stockwell, B.R.5
-
57
-
-
84937525519
-
Glutaminolysis and transferrin regulate ferroptosis
-
Gao, M.; Monian, P.; Quadri, N.; Ramasamy, R.; Jiang, X. Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell 2015, 59, 298-308.
-
(2015)
Mol. Cell
, vol.59
, pp. 298-308
-
-
Gao, M.1
Monian, P.2
Quadri, N.3
Ramasamy, R.4
Jiang, X.5
-
58
-
-
84943390843
-
Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
-
Kwon, M.Y.; Park, E.; Lee, S.J.; Chung, S.W. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget 2015, 6, 24393-24403.
-
(2015)
Oncotarget
, vol.6
, pp. 24393-24403
-
-
Kwon, M.Y.1
Park, E.2
Lee, S.J.3
Chung, S.W.4
-
59
-
-
84982123825
-
Ferroptosis is an autophagic cell death process
-
Gao, M.; Monian, P.; Pan, Q.; Zhang, W.; Xiang, J.; Jiang, X. Ferroptosis is an autophagic cell death process. Cell Res. 2016, 26, 1021-1032.
-
(2016)
Cell Res
, vol.26
, pp. 1021-1032
-
-
Gao, M.1
Monian, P.2
Pan, Q.3
Zhang, W.4
Xiang, J.5
Jiang, X.6
-
60
-
-
84926387317
-
Ferroptosis as a p53-mediated activity during tumour suppression
-
Jiang, L.; Kon, N.; Li, T.; Wang, S.J.; Su, T.; Hibshoosh, H.; Baer, R.; Gu, W. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 2015, 520, 57-62.
-
(2015)
Nature
, vol.520
, pp. 57-62
-
-
Jiang, L.1
Kon, N.2
Li, T.3
Wang, S.J.4
Su, T.5
Hibshoosh, H.6
Baer, R.7
Gu, W.8
-
61
-
-
84994059408
-
Activation of sat1 engages polyamine metabolism with p53-mediated ferroptotic responses
-
Ou, Y.; Wang, S.J.; Li, D.; Chu, B.; Gu, W. Activation of sat1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc. Natl. Acad. Sci. USA 2016, 113, E6806-E6812.
-
(2016)
Proc. Natl. Acad. Sci. USA
, vol.113
, pp. E6806-E6812
-
-
Ou, Y.1
Wang, S.J.2
Li, D.3
Chu, B.4
Gu, W.5
-
62
-
-
84861535833
-
Ironing out cell death mechanisms
-
Reed, J.C.; Pellecchia, M. Ironing out cell death mechanisms. Cell 2012, 149, 963-965.
-
(2012)
Cell
, vol.149
, pp. 963-965
-
-
Reed, J.C.1
Pellecchia, M.2
-
63
-
-
85018823202
-
HSPA5 regulates ferroptotic cell death in cancer cells
-
Zhu, S.; Zhang, Q.; Sun, X.; Zeh, H.J.; Lotze, M.T.; Kang, R.; Tang, D. HSPA5 regulates ferroptotic cell death in cancer cells. Cancer Res. 2017, 77, 2064-2077.
-
(2017)
Cancer Res
, vol.77
, pp. 2064-2077
-
-
Zhu, S.1
Zhang, Q.2
Sun, X.3
Zeh, H.J.4
Lotze, M.T.5
Kang, R.6
Tang, D.7
-
64
-
-
84968854657
-
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
-
Houessinon, A.; François, C.; Sauzay, C.; Louandre, C.; Mongelard, G.; Godin, C.; Bodeau, S.; Takahashi, S.; Saidak, Z.; Gutierrez, L. et al. Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib. Mol. Cancer 2016, 15, 38.
-
(2016)
Mol. Cancer
, vol.15
, pp. 38
-
-
Houessinon, A.1
François, C.2
Sauzay, C.3
Louandre, C.4
Mongelard, G.5
Godin, C.6
Bodeau, S.7
Takahashi, S.8
Saidak, Z.9
Gutierrez, L.10
-
65
-
-
84978997718
-
Metallothionein-1g facilitates sorafenib resistance through inhibition of ferroptosis
-
Sun, X.; Niu, X.; Chen, R.; He, W.; Chen, D.; Kang, R.; Tang, D. Metallothionein-1g facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology 2016, 64, 488-500.
-
(2016)
Hepatology
, vol.64
, pp. 488-500
-
-
Sun, X.1
Niu, X.2
Chen, R.3
He, W.4
Chen, D.5
Kang, R.6
Tang, D.7
-
66
-
-
0034623066
-
Inhibition of selenoprotein synthesis by selenocysteine tRNA[ser]sec lacking isopentenyladenosine
-
Warner, G.J.; Berry, M.J.; Moustafa, M.E.; Carlson, B.A.; Hatfield, D.L.; Faust, J.R. Inhibition of selenoprotein synthesis by selenocysteine tRNA[ser]sec lacking isopentenyladenosine. J. Biol. Chem. 2000, 275, 28110-28119.
-
(2000)
J. Biol. Chem
, vol.275
, pp. 28110-28119
-
-
Warner, G.J.1
Berry, M.J.2
Moustafa, M.E.3
Carlson, B.A.4
Hatfield, D.L.5
Faust, J.R.6
-
67
-
-
85009445471
-
The protective role of mitochondrial ferritin on erastin-induced ferroptosis. Front
-
Wang, Y.Q.; Chang, S.Y.; Wu, Q.; Gou, Y.J.; Jia, L.; Cui, Y.M.; Yu, P.; Shi, Z.H.; Wu, W.S.; Gao, G. et al. The protective role of mitochondrial ferritin on erastin-induced ferroptosis. Front. Aging Neurosci. 2016, 8, 308.
-
(2016)
Aging Neurosci
, vol.8
, pp. 308
-
-
Wang, Y.Q.1
Chang, S.Y.2
Wu, Q.3
Gou, Y.J.4
Jia, L.5
Cui, Y.M.6
Yu, P.7
Shi, Z.H.8
Wu, W.S.9
Gao, G.10
-
68
-
-
84952639010
-
Activation of the p62-KEAP1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
-
Sun, X.; Ou, Z.; Chen, R.; Niu, X.; Chen, D.; Kang, R.; Tang, D. Activation of the p62-KEAP1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 2016, 63, 173-184.
-
(2016)
Hepatology
, vol.63
, pp. 173-184
-
-
Sun, X.1
Ou, Z.2
Chen, R.3
Niu, X.4
Chen, D.5
Kang, R.6
Tang, D.7
-
69
-
-
0344887930
-
-
IARC: Lyon, France
-
Fletcher, C.D.M.; Bridge, J.A.; Hogendoorn, P.C.W.; Mertens, F. Who Classification of Tumours of Soft Tissue and Bone; IARC: Lyon, France, 2013.
-
(2013)
Who Classification of Tumours of Soft Tissue and Bone
-
-
Fletcher, C.D.M.1
Bridge, J.A.2
Hogendoorn, P.C.W.3
Mertens, F.4
-
70
-
-
19644366513
-
Genetic modeling of human rhabdomyosarcoma
-
Linardic, C.M.; Downie, D.L.; Qualman, S.; Bentley, R.C.; Counter, C.M. Genetic modeling of human rhabdomyosarcoma. Cancer Res. 2005, 65, 4490-4495.
-
(2005)
Cancer Res
, vol.65
, pp. 4490-4495
-
-
Linardic, C.M.1
Downie, D.L.2
Qualman, S.3
Bentley, R.C.4
Counter, C.M.5
-
71
-
-
84055178989
-
Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells
-
Hettmer, S.; Liu, J.; Miller, C.M.; Lindsay, M.C.; Sparks, C.A.; Guertin, D.A.; Bronson, R.T.; Langenau, D.M.; Wagers, A.J. Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells. Proc. Natl. Acad. Sci. USA 2011, 108, 20002-20007.
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 20002-20007
-
-
Hettmer, S.1
Liu, J.2
Miller, C.M.3
Lindsay, M.C.4
Sparks, C.A.5
Guertin, D.A.6
Bronson, R.T.7
Langenau, D.M.8
Wagers, A.J.9
-
72
-
-
79751484162
-
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma
-
Rubin, B.P.; Nishijo, K.; Chen, H.I.; Yi, X.; Schuetze, D.P.; Pal, R.; Prajapati, S.I.; Abraham, J.; Arenkiel, B.R.; Chen, Q.R. et al. Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 2011, 19, 177-191.
-
(2011)
Cancer Cell
, vol.19
, pp. 177-191
-
-
Rubin, B.P.1
Nishijo, K.2
Chen, H.I.3
Yi, X.4
Schuetze, D.P.5
Pal, R.6
Prajapati, S.I.7
Abraham, J.8
Arenkiel, B.R.9
Chen, Q.R.10
-
73
-
-
84855477391
-
Modeling sarcomagenesis using multipotent mesenchymal stem cells
-
Rodriguez, R.; Rubio, R.; Menendez, P. Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res. 2012, 22, 62-77.
-
(2012)
Cell Res
, vol.22
, pp. 62-77
-
-
Rodriguez, R.1
Rubio, R.2
Menendez, P.3
-
74
-
-
84858763270
-
Myogenic tumors in children and adolescents
-
Parham, D.M.; Alaggio, R.; Coffin, C.M. Myogenic tumors in children and adolescents. Pediatr. Dev. Pathol. 2012, 15, 211-238.
-
(2012)
Pediatr. Dev. Pathol
, vol.15
, pp. 211-238
-
-
Parham, D.M.1
Alaggio, R.2
Coffin, C.M.3
-
75
-
-
84933040183
-
Probing for a deeper understanding of rhabdomyosarcoma: Insights from complementary model systems
-
Kashi, V.P.; Hatley, M.E.; Galindo, R.L. Probing for a deeper understanding of rhabdomyosarcoma: Insights from complementary model systems. Nat. Rev. Cancer 2015, 15, 426-439.
-
(2015)
Nat. Rev. Cancer
, vol.15
, pp. 426-439
-
-
Kashi, V.P.1
Hatley, M.E.2
Galindo, R.L.3
-
76
-
-
84896691170
-
Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors
-
Shern, J.F.; Chen, L.; Chmielecki, J.; Wei, J.S.; Patidar, R.; Rosenberg, M.; Ambrogio, L.; Auclair, D.; Wang, J.; Song, Y.K. et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov. 2014, 4, 216-231.
-
(2014)
Cancer Discov
, vol.4
, pp. 216-231
-
-
Shern, J.F.1
Chen, L.2
Chmielecki, J.3
Wei, J.S.4
Patidar, R.5
Rosenberg, M.6
Ambrogio, L.7
Auclair, D.8
Wang, J.9
Song, Y.K.10
-
77
-
-
70449450426
-
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
-
Taylor, J.G.; Cheuk, A.T.; Tsang, P.S.; Chung, J.Y.; Song, Y.K.; Desai, K.; Yu, Y.; Chen, Q.R.; Shah, K.; Youngblood, V. et al. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J. Clin. Investig. 2009, 119, 3395-3407.
-
(2009)
J. Clin. Investig
, vol.119
, pp. 3395-3407
-
-
Taylor, J.G.1
Cheuk, A.T.2
Tsang, P.S.3
Chung, J.Y.4
Song, Y.K.5
Desai, K.6
Yu, Y.7
Chen, Q.R.8
Shah, K.9
Youngblood, V.10
-
78
-
-
0024388736
-
Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction
-
Stratton, M.R.; Fisher, C.; Gusterson, B.A.; Cooper, C.S. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res. 1989, 49, 6324-6327.
-
(1989)
Cancer Res
, vol.49
, pp. 6324-6327
-
-
Stratton, M.R.1
Fisher, C.2
Gusterson, B.A.3
Cooper, C.S.4
-
79
-
-
84856555606
-
Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways
-
Shukla, N.; Ameur, N.; Yilmaz, I.; Nafa, K.; Lau, C.Y.; Marchetti, A.; Borsu, L.; Barr, F.G.; Ladanyi, M. Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clin. Cancer Res. 2012, 18, 748-757.
-
(2012)
Clin. Cancer Res
, vol.18
, pp. 748-757
-
-
Shukla, N.1
Ameur, N.2
Yilmaz, I.3
Nafa, K.4
Lau, C.Y.5
Marchetti, A.6
Borsu, L.7
Barr, F.G.8
Ladanyi, M.9
-
80
-
-
0009615132
-
A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting
-
Scrable, H.; Cavenee, W.; Ghavimi, F.; Lovell, M.; Morgan, K.; Sapienza, C.C.P. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl. Acad. Sci. USA 1989, 86, 7480-7484.
-
(1989)
Proc. Natl. Acad. Sci. USA
, vol.86
, pp. 7480-7484
-
-
Scrable, H.1
Cavenee, W.2
Ghavimi, F.3
Lovell, M.4
Morgan, K.5
Sapienza, C.6
-
81
-
-
0033205985
-
Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma
-
Anderson, J.; Gordon, A.; McManus, A.; Shipley, J.; Pritchard-Jones, K. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia 1999, 1, 340-348.
-
(1999)
Neoplasia
, vol.1
, pp. 340-348
-
-
Anderson, J.1
Gordon, A.2
McManus, A.3
Shipley, J.4
Pritchard-Jones, K.5
-
82
-
-
0033861106
-
P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines
-
Taylor, A.C.; Shu, L.; Danks, M.K.; Poquette, C.A.; Shetty, S.; Thayer, M.J.; Houghton, P.J.; Harris, L.C. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med. Pediatr. Oncol. 2000, 35, 96-103.
-
(2000)
Med. Pediatr. Oncol
, vol.35
, pp. 96-103
-
-
Taylor, A.C.1
Shu, L.2
Danks, M.K.3
Poquette, C.A.4
Shetty, S.5
Thayer, M.J.6
Houghton, P.J.7
Harris, L.C.8
-
83
-
-
84879431387
-
PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children’s oncology group report
-
Skapek, S.X.; Anderson, J.; Barr, F.G.; Bridge, J.A.; Gastier-Foster, J.M.; Parham, D.M.; Rudzinski, E.R.; Triche, T.; Hawkins, D.S. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children’s oncology group report. Pediatr. Blood Cancer 2013, 60, 1411-1417.
-
(2013)
Pediatr. Blood Cancer
, vol.60
, pp. 1411-1417
-
-
Skapek, S.X.1
Anderson, J.2
Barr, F.G.3
Bridge, J.A.4
Gastier-Foster, J.M.5
Parham, D.M.6
Rudzinski, E.R.7
Triche, T.8
Hawkins, D.S.9
-
84
-
-
84863748866
-
PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification
-
Missiaglia, E.; Williamson, D.; Chisholm, J.; Wirapati, P.; Pierron, G.; Petel, F.; Concordet, J.P.; Thway, K.; Oberlin, O.; Pritchard-Jones, K. et al. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. J. Clin. Oncol. 2012, 30, 1670-1677.
-
(2012)
J. Clin. Oncol
, vol.30
, pp. 1670-1677
-
-
Missiaglia, E.1
Williamson, D.2
Chisholm, J.3
Wirapati, P.4
Pierron, G.5
Petel, F.6
Concordet, J.P.7
Thway, K.8
Oberlin, O.9
Pritchard-Jones, K.10
-
85
-
-
43049183354
-
Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: Focus on mycn as a biologically relevant target
-
Mercado, G.E.; Xia, S.J.; Zhang, C.; Ahn, E.H.; Gustafson, D.M.; Laé, M.; Ladanyi, M.; Barr, F.G. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: Focus on mycn as a biologically relevant target. Genes Chromosomes Cancer 2008, 47, 510-520.
-
(2008)
Genes Chromosomes Cancer
, vol.47
, pp. 510-520
-
-
Mercado, G.E.1
Xia, S.J.2
Zhang, C.3
Ahn, E.H.4
Gustafson, D.M.5
Laé, M.6
Ladanyi, M.7
Barr, F.G.8
-
86
-
-
76649129867
-
Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family
-
Sumegi, J.; Streblow, R.; Frayer, R.W.; Dal Cin, P.; Rosenberg, A.; Meloni-Ehrig, A.; Bridge, J.A. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Genes Chromosomes Cancer 2010, 49, 224-236.
-
(2010)
Genes Chromosomes Cancer
, vol.49
, pp. 224-236
-
-
Sumegi, J.1
Streblow, R.2
Frayer, R.W.3
Dal Cin, P.4
Rosenberg, A.5
Meloni-Ehrig, A.6
Bridge, J.A.7
-
87
-
-
84904332096
-
Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: Evidence for a common pathogenesis
-
Agaram, N.P.; Chen, C.L.; Zhang, L.; LaQuaglia, M.P.; Wexler, L.; Antonescu, C.R. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: Evidence for a common pathogenesis. Genes Chromosomes Cancer 2014, 53, 779-787.
-
(2014)
Genes Chromosomes Cancer
, vol.53
, pp. 779-787
-
-
Agaram, N.P.1
Chen, C.L.2
Zhang, L.3
Laquaglia, M.P.4
Wexler, L.5
Antonescu, C.R.6
-
88
-
-
84886558872
-
Classification of rhabdomyosarcoma and its molecular basis
-
Parham, D.M.; Barr, F.G. Classification of rhabdomyosarcoma and its molecular basis. Adv. Anat. Pathol. 2013, 20, 387-397.
-
(2013)
Adv. Anat. Pathol.
, vol.20
, pp. 387-397
-
-
Parham, D.M.1
Barr, F.G.2
-
89
-
-
70149121277
-
Trends in childhood rhabdomyosarcoma incidence and survival in the united states, 1975-2005
-
Ognjanovic, S.; Linabery, A.M.; Charbonneau, B.; Ross, J.A.C.P. Trends in childhood rhabdomyosarcoma incidence and survival in the united states, 1975-2005. Cancer 2009, 115, 4218-4226.
-
(2009)
Cancer
, vol.115
, pp. 4218-4226
-
-
Ognjanovic, S.1
Linabery, A.M.2
Charbonneau, B.3
Ross, J.A.C.P.4
-
90
-
-
84908425477
-
Rhabdomyosarcoma: Current challenges and their implications for developing therapies
-
Hettmer, S.; Li, Z.; Billin, A.N.; Barr, F.G.; Cornelison, D.D.; Ehrlich, A.R.; Guttridge, D.C.; Hayes-Jordan, A.; Helman, L.J.; Houghton, P.J. et al. Rhabdomyosarcoma: Current challenges and their implications for developing therapies. Cold Spring Harb. Perspect. Med. 2014, 4, a025650.
-
(2014)
Cold Spring Harb. Perspect. Med
, vol.4
-
-
Hettmer, S.1
Li, Z.2
Billin, A.N.3
Barr, F.G.4
Cornelison, D.D.5
Ehrlich, A.R.6
Guttridge, D.C.7
Hayes-Jordan, A.8
Helman, L.J.9
Houghton, P.J.10
-
91
-
-
84863102116
-
Rhabdomyosarcomas: An overview on the experimental animal models
-
Zanola, A.; Rossi, S.; Faggi, F.; Monti, E.; Fanzani, A. Rhabdomyosarcomas: An overview on the experimental animal models. J. Cell Mol. Med. 2012, 16, 1377-1391.
-
(2012)
J. Cell Mol. Med
, vol.16
, pp. 1377-1391
-
-
Zanola, A.1
Rossi, S.2
Faggi, F.3
Monti, E.4
Fanzani, A.5
-
92
-
-
0027366917
-
Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma
-
Shapiro, D.N.; Sublett, J.E.; Li, B.; Downing, J.R.; Naeve, C.W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 1993, 53, 5108-5112.
-
(1993)
Cancer Res
, vol.53
, pp. 5108-5112
-
-
Shapiro, D.N.1
Sublett, J.E.2
Li, B.3
Downing, J.R.4
Naeve, C.W.5
-
93
-
-
0027521658
-
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
-
Galili, N.; Davis, R.J.; Fredericks, W.J.; Mukhopadhyay, S.; Rauscher, F.J.; Emanuel, B.S.; Rovera, G.; Barr, F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 1993, 5, 230-235.
-
(1993)
Nat. Genet
, vol.5
, pp. 230-235
-
-
Galili, N.1
Davis, R.J.2
Fredericks, W.J.3
Mukhopadhyay, S.4
Rauscher, F.J.5
Emanuel, B.S.6
Rovera, G.7
Barr, F.G.8
-
94
-
-
34249905448
-
Effects of ras on the genesis of embryonal rhabdomyosarcoma
-
Langenau, D.M.; Keefe, M.D.; Storer, N.Y.; Guyon, J.R.; Kutok, J.L.; Le, X.; Goessling, W.; Neuberg, D.S.; Kunkel, L.M.; Zon, L.I.C.P. Effects of ras on the genesis of embryonal rhabdomyosarcoma. Genes Dev. 2007, 21, 1382-1395.
-
(2007)
Genes Dev
, vol.21
, pp. 1382-1395
-
-
Langenau, D.M.1
Keefe, M.D.2
Storer, N.Y.3
Guyon, J.R.4
Kutok, J.L.5
Le, X.6
Goessling, W.7
Neuberg, D.S.8
Kunkel, L.M.9
Zon, L.I.C.P.10
-
95
-
-
0023354739
-
The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation
-
Olson, E.N.; Spizz, G.; Tainsky, M.A. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol. Cell Biol. 1987, 7, 2104-2111.
-
(1987)
Mol. Cell Biol
, vol.7
, pp. 2104-2111
-
-
Olson, E.N.1
Spizz, G.2
Tainsky, M.A.3
-
96
-
-
27144531386
-
Germline mutations in hras proto-oncogene cause costello syndrome
-
Aoki, Y.; Niihori, T.; Kawame, H.; Kurosawa, K.; Ohashi, H.; Tanaka, Y.; Filocamo, M.; Kato, K.; Suzuki, Y.; Kure, S. et al. Germline mutations in hras proto-oncogene cause costello syndrome. Nat. Genet. 2005, 37, 1038-1040.
-
(2005)
Nat. Genet
, vol.37
, pp. 1038-1040
-
-
Aoki, Y.1
Niihori, T.2
Kawame, H.3
Kurosawa, K.4
Ohashi, H.5
Tanaka, Y.6
Filocamo, M.7
Kato, K.8
Suzuki, Y.9
Kure, S.10
-
97
-
-
84891953948
-
Targeting oxidative stress in embryonal rhabdomyosarcoma
-
Chen, X.; Stewart, E.; Shelat, A.A.; Qu, C.; Bahrami, A.; Hatley, M.; Wu, G.; Bradley, C.; McEvoy, J.; Pappo, A. et al. Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell 2013, 24, 710-724.
-
(2013)
Cancer Cell
, vol.24
, pp. 710-724
-
-
Chen, X.1
Stewart, E.2
Shelat, A.A.3
Qu, C.4
Bahrami, A.5
Hatley, M.6
Wu, G.7
Bradley, C.8
McEvoy, J.9
Pappo, A.10
-
98
-
-
84891960617
-
RAS and ROS in rhabdomyosarcoma
-
Zhang, M.; Linardic, C.M.; Kirsch, D.G. RAS and ROS in rhabdomyosarcoma. Cancer Cell 2013, 24, 689-691.
-
(2013)
Cancer Cell
, vol.24
, pp. 689-691
-
-
Zhang, M.1
Linardic, C.M.2
Kirsch, D.G.3
-
99
-
-
84866915080
-
Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents
-
Liu, Y.; Li, Y.; Yu, S.; Zhao, G. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents. Curr. Drug Targets 2012, 13, 1432-1444.
-
(2012)
Curr. Drug Targets
, vol.13
, pp. 1432-1444
-
-
Liu, Y.1
Li, Y.2
Yu, S.3
Zhao, G.4
-
100
-
-
84856108187
-
Opposite effects of statins on mitochondria of cardiac and skeletal muscles: A “mitohormesis” mechanism involving reactive oxygen species and PGC-1
-
Bouitbir, J.; Charles, A.L.; Echaniz-Laguna, A.; Kindo, M.; Daussin, F.; Auwerx, J.; Piquard, F.; Geny, B.; Zoll, J. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: A “mitohormesis” mechanism involving reactive oxygen species and PGC-1. Eur. Heart J. 2012, 33, 1397-1407.
-
(2012)
Eur. Heart J.
, vol.33
, pp. 1397-1407
-
-
Bouitbir, J.1
Charles, A.L.2
Echaniz-Laguna, A.3
Kindo, M.4
Daussin, F.5
Auwerx, J.6
Piquard, F.7
Geny, B.8
Zoll, J.9
-
101
-
-
0036256133
-
Role of γ-glutamyltranspeptidase on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to buthionine sulfoximine-induced inhibition of glutathione synthesis
-
Castro, B.; Alonso-Varona, A.; del Olmo, M.; Bilbao, P.; Palomares, T. Role of γ-glutamyltranspeptidase on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to buthionine sulfoximine-induced inhibition of glutathione synthesis. Anticancer Drugs 2002, 13, 281-291.
-
(2002)
Anticancer Drugs
, vol.13
, pp. 281-291
-
-
Castro, B.1
Alonso-Varona, A.2
Del Olmo, M.3
Bilbao, P.4
Palomares, T.5
-
102
-
-
79960809400
-
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: A promising therapeutic strategy
-
Pasello, M.; Manara, M.C.; Michelacci, F.; Fanelli, M.; Hattinger, C.M.; Nicoletti, G.; Landuzzi, L.; Lollini, P.L.; Caccuri, A.; Picci, P. et al. Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: A promising therapeutic strategy. Anal. Cell. Pathol. (AMST) 2011, 34, 131-145.
-
(2011)
Anal. Cell. Pathol. (AMST)
, vol.34
, pp. 131-145
-
-
Pasello, M.1
Manara, M.C.2
Michelacci, F.3
Fanelli, M.4
Hattinger, C.M.5
Nicoletti, G.6
Landuzzi, L.7
Lollini, P.L.8
Caccuri, A.9
Picci, P.10
-
103
-
-
84857960918
-
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling
-
Maruwge, W.; D’Arcy, P.; Folin, A.; Brnjic, S.; Wejde, J.; Davis, A.; Erlandsson, F.; Bergh, J.; Brodin, B. Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling. Onco Targets Ther. 2008, 1, 67-78.
-
(2008)
Onco Targets Ther
, vol.1
, pp. 67-78
-
-
Maruwge, W.1
D’Arcy, P.2
Folin, A.3
Brnjic, S.4
Wejde, J.5
Davis, A.6
Erlandsson, F.7
Bergh, J.8
Brodin, B.9
-
104
-
-
84934269293
-
Oncogenic RAS mutants confer resistance of RMS13 rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death
-
Schott, C.; Graab, U.; Cuvelier, N.; Hahn, H.; Fulda, S. Oncogenic RAS mutants confer resistance of RMS13 rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death. Front. Oncol. 2015, 5, 131.
-
(2015)
Front. Oncol
, vol.5
, pp. 131
-
-
Schott, C.1
Graab, U.2
Cuvelier, N.3
Hahn, H.4
Fulda, S.5
-
105
-
-
0031156696
-
Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma
-
Hochwald, S.N.; Rose, D.M.; Brennan, M.F.; Burt, M.E. Elevation of glutathione and related enzyme activities in high-grade and metastatic extremity soft tissue sarcoma. Ann. Surg. Oncol. 1997, 4, 303-309.
-
(1997)
Ann. Surg. Oncol
, vol.4
, pp. 303-309
-
-
Hochwald, S.N.1
Rose, D.M.2
Brennan, M.F.3
Burt, M.E.4
-
106
-
-
75449102372
-
Inhibition of glutathione-s-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma
-
Seitz, G.; Bonin, M.; Fuchs, J.; Poths, S.; Ruck, P.; Warmann, S.W.; Armeanu-Ebinger, S. Inhibition of glutathione-s-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma. Int. J. Oncol. 2010, 36, 491-500.
-
(2010)
Int. J. Oncol
, vol.36
, pp. 491-500
-
-
Seitz, G.1
Bonin, M.2
Fuchs, J.3
Poths, S.4
Ruck, P.5
Warmann, S.W.6
Armeanu-Ebinger, S.7
-
107
-
-
84867252538
-
Redox status expressed as GSH: GSSG ratio as a marker for oxidative stress in paediatric tumour patients
-
Zitka, O.; Skalickova, S.; Gumulec, J.; Masarik, M.; Adam, V.; Hubalek, J.; Trnkova, L.; Kruseova, J.; Eckschlager, T.; Kizek, R. Redox status expressed as GSH: GSSG ratio as a marker for oxidative stress in paediatric tumour patients. Oncol. Lett. 2012, 4, 1247-1253.
-
(2012)
Oncol. Lett
, vol.4
, pp. 1247-1253
-
-
Zitka, O.1
Skalickova, S.2
Gumulec, J.3
Masarik, M.4
Adam, V.5
Hubalek, J.6
Trnkova, L.7
Kruseova, J.8
Eckschlager, T.9
Kizek, R.10
-
108
-
-
84938205370
-
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the children’s oncology group
-
Kim, A.; Widemann, B.C.; Krailo, M.; Jayaprakash, N.; Fox, E.; Weigel, B.; Blaney, S.M. Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the children’s oncology group. Pediatr. Blood Cancer 2015, 62, 1562-1566.
-
(2015)
Pediatr. Blood Cancer
, vol.62
, pp. 1562-1566
-
-
Kim, A.1
Widemann, B.C.2
Krailo, M.3
Jayaprakash, N.4
Fox, E.5
Weigel, B.6
Blaney, S.M.7
-
109
-
-
30344481701
-
γ-glutamyl transpeptidase in glutathione biosynthesis
-
Zhang, H.; Forman, H.J.; Choi, J. γ-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol. 2005, 401, 468-483.
-
(2005)
Methods Enzymol
, vol.401
, pp. 468-483
-
-
Zhang, H.1
Forman, H.J.2
Choi, J.3
-
110
-
-
0034454142
-
Removal of N-glycans from cell surface proteins induces apoptosis by reducing intracellular glutathione levels in the rhabdomyosarcoma cell line s4mh
-
Calle, Y.; Palomares, T.; Castro, B.; del Olmo, M.; Alonso-Varona, A. Removal of N-glycans from cell surface proteins induces apoptosis by reducing intracellular glutathione levels in the rhabdomyosarcoma cell line s4mh. Biol. Cell 2000, 92, 639-646.
-
(2000)
Biol. Cell
, vol.92
, pp. 639-646
-
-
Calle, Y.1
Palomares, T.2
Castro, B.3
Del Olmo, M.4
Alonso-Varona, A.5
-
111
-
-
80051675493
-
Autocatalytic cleavage of human γ-glutamyl transpeptidase is highly dependent on N-glycosylation at asparagine 95
-
West, M.B.; Wickham, S.; Quinalty, L.M.; Pavlovicz, R.E.; Li, C.; Hanigan, M.H. Autocatalytic cleavage of human γ-glutamyl transpeptidase is highly dependent on N-glycosylation at asparagine 95. J. Biol. Chem. 2011, 286, 28876-28888.
-
(2011)
J. Biol. Chem
, vol.286
, pp. 28876-28888
-
-
West, M.B.1
Wickham, S.2
Quinalty, L.M.3
Pavlovicz, R.E.4
Li, C.5
Hanigan, M.H.6
|